January 23, 2017
Jan 23, 2017
Accel Biotech, a Ximedica company, is heading to Washington DC this February to exhibit at SLAS2017. This international conference and exhibition put on by the Society for Laboratory Automation and Screening (SLAS) will be an exciting opportunity to meet some of our team and explore innovation in lab automation.
We will be showcasing our AsysTekTM Product Family, our flexible and scalable automation products that provide solutions for a wide variety of applications. Come talk to us about how these products, coupled with our experienced team, can accelerate your product development.
Join us at SLAS2017 and be part of the excitement surrounding this world-class scientific event where global leaders from life sciences discovery and technology will come together in Washington, DC from February 4 – 8.
Find us at booth #1342!
For complete event information, visit www.SLAS2017.org.
Check out our other upcoming events!
We will also be joining Ximedica in their booth at MD&M West in Anaheim. Check out booth #1367 to find out more about how Accel Biotech and Ximedica can help you in your product development process.
About Accel Biotech
Accel Biotech, located in Northern California’s Silicon Valley, is a full-service contract development and manufacturing firm. Our mission at Accel Biotech is to pair our unique breadth of engineering and design experience in diagnostics, life sciences and disposables with a passion for quick development. We enable rapid prototyping with in-house machining, 3D printing and full production runs for complex devices. We value customer satisfaction above all else, seeking long-lasting relationships with our clients.
SLAS serves a global community of life sciences research and development (R&D) professionals from academia, government and industry through education, information and unique access. SLAS provides the gateway for these scientists, researchers, engineers and technology providers to stay on top of innovative breakthroughs in scientific technology, and to work together to achieve objectives for themselves, their organizations and the industry as a whole.